Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Canadian Health Industry News.
Press releases published on May 5, 2025

Veteran WordPress Developer David Repasky to Speak on AI-Enhanced Development at AI Tinkerers Event
Discover how BMA’s lead developer is transforming web workflows with GPT-4.1 and o3-mini. IRVINE, CA, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- David Repasky, Senior Web Developer at BMA (Branding | Marketing | Advertising), will be presenting at …

Still Water Wellness Group Launches Innovative Couples Rehab Program in Orange County
Still Water Wellness expands couples rehab program to meet growing demand in Orange County. ORANGE COUNTY, CA, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- Still Water Wellness Group, a leading addiction treatment center in Orange County, has …

Oceans Luxury Rehab Unveils Expanded Oceanfront Treatment Facilities in Orange County
Oceans Luxury Rehab in Orange County introduces a Luxury Rehab Program, emphasizing confidentiality and high-end treatment. ORANGE COUNTY, CA, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- Oceans Luxury Rehab, a premier luxury rehab California …

The Silent Struggle: Understanding the Mental Health Effects of Bullying
Join Stand for the Silent in Their Mission to Support Affected Students and Foster Resilience. OKLAHOMA CITY, OKLA. , OK, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- May is National Mental Health Awareness Month, making it a great time to put an …

GenCare Lifestyle Launches "Through Their Eyes", Offering Insight into Grandparents from their Grandchildren
GenCare Lifestyle Senior Living launches Through Their Eyes — and celebrates grandparents with Mother's Day and Father's Day events SEATTLE, WA, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- GenCare Lifestyle Senior Living, a premier senior living …

SignPath Pharma Announces ASCO 2025 Abstract Featuring LipoCurc for Glioblastoma
Phase I/II study of LipoCurc™ in glioblastoma accepted for poster presentation at ASCO 2025, in collaboration with Johns Hopkins. SANDY, UT, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- SignPath Pharma, Inc., a Delaware-incorporated clinical-stage …

AgileOne Recognized as Top Global MSP Provider by HRO Today
AgileOne is honored to share that the company has been selected as the top global Managed Service Provider (MSP) by HRO Today. TORRANCE, CA, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- AgileOne is honored to share that the company has been selected …

Global Safety Leaders Convene in Riyadh for Record-Breaking Occupational Safety and Health Conference
Largest, most international edition to date and one of the leading occupational safety and health conferences RIYADH, SAUDI ARABIA, May 5, 2025 /EINPresswire.com/ -- High-profile international event gathers global leaders in occupational safety and …

Xenon to Report Q1 2025 Financial Results on May 12, 2025
VANCOUVER, British Columbia and BOSTON, May 05, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for …

How individuals grasp an object may offer simpler diagnosis for autism spectrum disorder
Toronto, May 05, 2025 (GLOBE NEWSWIRE) -- Getting a timely diagnosis of autism spectrum disorder is a major challenge, but new research out of York University shows that how young adults, and potentially children, grasp objects could offer a simpler way to …

MicroRNAs Research Initiative in Glioblastoma Stem Cells Awarded $85K by Brain Cancer Canada
TORONTO, May 05, 2025 (GLOBE NEWSWIRE) -- Brain Cancer Canada is pleased to announce a $85,000 grant for a cutting-edge research initiative led by Dr. Leonardo Salmena at the University of Toronto. The project, titled “Exploring microRNA as Targets for …

Cannabix Technologies Receives NHTSA Approval for BreathLogix Workplace Series Alcohol Breathalyzer
VANCOUVER, British Columbia, May 05, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) reports that it has received notice from the U.S. National Highway Traffic Safety Association …

Rakovina Therapeutics Announces Appointment of Dr. David Kideckel as Chief Financial Officer
VANCOUVER, British Columbia, May 05, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered …

Algernon Announces Warrant Extension
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 05, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) (the “Company …

Microbix’s Clot-Buster Drug Project Advances
MISSISSAUGA, Ontario, May 05, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that its funding and commercialization partner, Sequel Pharma, LLC (“ …

Eupraxia Pharmaceuticals Announces Sustained Positive Treatment Outcomes in Patients with Eosinophilic Esophagitis (EoE) After Nine Months of Receiving EP-104GI
Eupraxia continues to observe positive treatment outcomes in its ongoing Phase 1b/2a trial, including for the first time clinical responses measured 9 months after dosing with EP-104GI At 9 months active drug continued to be released into the esophagus in …